Antidepressant withdrawal: The hidden danger New benchmark guidelines highlight the dangers of antidepressant withdrawal and support GPs in safe deprescribing.
Primary care at the heart of social prescribing national rollout The RACGP was part of a recent roundtable discussion aimed at broadening the landscape of social prescribing in Australia.
Funding helps mobile GP clinic treating ‘forgotten’ patients roll on It is free, accessible, and non-judgemental. And for more than 20 years, Street Doctor has brought healthcare to those who would otherwise go without.
Exercise must be ‘core treatment’ for depression: Study Researchers have urged GPs to prescribe physical activity alongside traditional interventions, with yoga and strength training especially beneficial.
Loneliness epidemic plaguing young Australians GPs are being urged to warn young patients of the ‘insidious harms of online interactions’ as data reveals 42% are experiencing distress.
Patient violence in general practice not ‘just part of the job’ With violence against healthcare workers increasing, Professor Leanne Rowe details steps GPs can take to protect themselves and their colleagues.
Why GPs don’t need to have all the answers Dr Tim Jones writes about how an empowering exchange with one of his patient’s teachers helped spread the load and deliver outstanding results.
Opioid use in pregnancy linked to childhood illness According to new research, women who used opioids during pregnancy are more likely to have children with infections, eczema and asthma later in life.
Antipsychotics spiking cardiac risks: Study Researchers have revealed 10% of patients on quetiapine and haloperidol develop heart rhythm disorders, leading to calls for increased monitoring.
Does montelukast need a warning label? The asthma medication is known to cause behavioural and neuropsychiatric disturbance that in rare cases have been linked to suicidal ideation.